Related Experiment Video
Updated: Apr 17, 2026
12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
10.4K
Evolution of oncolytic viruses
Rafael Sanjuán1, Valery Z Grdzelishvili2
1Instituto Cavanilles de Biodiversidad y Biologia Evolutiva and Departament de Genètica, Universitat de València, Valencia, Spain.
Current Opinion in Virology
|February 21, 2015
Summary
Oncolytic viruses (OVs) can evolve, posing safety risks or offering opportunities for enhancement. Directed evolution in the lab can create improved OVs, bypassing complex virus-host interactions for better cancer therapy.
Area of Science:
- Virology
- Evolutionary Biology
- Biotechnology
Background:
- Oncolytic viruses (OVs) possess replicative capabilities, enabling evolution via natural selection.
- Potential evolutionary risks include reversion to virulence and recombination with wild-type strains, necessitating safety assessments.
- Directed evolution offers an alternative strategy to traditional genetic engineering for developing novel OVs.
Purpose of the Study:
- To explore the potential of directed evolution for creating enhanced oncolytic viruses.
- To investigate how evolutionary principles can be applied to improve OV safety and efficacy.
- To present directed evolution as a viable alternative to genetic engineering for OV development.
Main Methods:
- Leveraging principles from experimental evolution studies.
- Applying directed evolution strategies to oncolytic viruses in laboratory settings.
- Analyzing evolutionary trajectories and outcomes of OV populations.
Main Results:
- Directed evolution can be utilized to generate oncolytic viruses with potentially improved characteristics.
- This approach circumvents limitations associated with understanding complex virus-host interactions.
- Identified exploitable features from previous experimental evolution work.
Conclusions:
- Directed evolution is a powerful tool for developing safer and more potent oncolytic viruses.
- It offers a complementary approach to genetic engineering in oncolytic virotherapy.
- This strategy allows for the creation of novel OVs irrespective of underlying molecular mechanisms.
Related Concept Videos
00:36Viral Mutations
41.1K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
41.1K
01:03Rous Sarcoma Virus (RSV) and Cancer
6.7K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.7K
01:03Rous Sarcoma Virus (RSV) and Cancer
6.1K
6.1K
00:57Viral Recombination
25.9K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
25.9K
01:51Mechanisms of Retrovirus-induced Cancers
7.3K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.3K
01:51Mechanisms of Retrovirus-induced Cancers
3.2K
3.2K